These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 7817819

  • 41. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
    Abildgaard N, Glerup H, Rungby J, Bendix-Hansen K, Kassem M, Brixen K, Heickendorff L, Nielsen JL, Eriksen EF.
    Eur J Haematol; 2000 Feb; 64(2):121-9. PubMed ID: 10997332
    [Abstract] [Full Text] [Related]

  • 42. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women.
    Lomri A, Marie PJ.
    J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773
    [Abstract] [Full Text] [Related]

  • 43. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
    Crofton PM, Ahmed SF, Wade JC, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH.
    Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
    [Abstract] [Full Text] [Related]

  • 44. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

  • 45. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
    Hansen TB, Brixen K, Vahl N, Jørgensen JO, Christiansen JS, Mosekilde L, Hagen C.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
    [Abstract] [Full Text] [Related]

  • 46. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
    Gorai I, Taguchi Y, Chaki O, Kikuchi R, Nakayama M, Yang BC, Yokota S, Minaguchi H.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
    [Abstract] [Full Text] [Related]

  • 47. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
    Lee DG, Park SY, Chung WS, Park JH, Shin HS, Hwang E, Kim IH, Yi TH.
    Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
    [Abstract] [Full Text] [Related]

  • 48. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover.
    Sartorio A, Conti A, Monzani M, Morabito F, Faglia G.
    J Endocrinol Invest; 1993 Dec; 16(11):893-8. PubMed ID: 8144866
    [Abstract] [Full Text] [Related]

  • 49. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
    Hannon R, Blumsohn A, Naylor K, Eastell R.
    J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076
    [Abstract] [Full Text] [Related]

  • 50. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis.
    Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY.
    J Bone Miner Res; 1995 Aug; 10(8):1218-24. PubMed ID: 8585426
    [Abstract] [Full Text] [Related]

  • 51. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures.
    Baek KH, Oh KW, Lee WY, Lee SS, Kim MK, Kwon HS, Rhee EJ, Han JH, Song KH, Cha BY, Lee KW, Kang MI.
    Calcif Tissue Int; 2010 Sep; 87(3):226-35. PubMed ID: 20614110
    [Abstract] [Full Text] [Related]

  • 52. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
    Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG.
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
    [Abstract] [Full Text] [Related]

  • 53. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults.
    Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):81-7. PubMed ID: 9435420
    [Abstract] [Full Text] [Related]

  • 54. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [Abstract] [Full Text] [Related]

  • 55. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
    Brahm H, Ljunggren O, Larsson K, Lindh E, Ljunghall S.
    Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
    [Abstract] [Full Text] [Related]

  • 56. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.
    Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y.
    Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414
    [Abstract] [Full Text] [Related]

  • 57. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts.
    Chihara K, Sugimoto T.
    Horm Res; 1997 Oct; 48 Suppl 5():45-9. PubMed ID: 9434044
    [Abstract] [Full Text] [Related]

  • 58. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
    Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher JC, Pavo I, Wang J, Eriksen EF.
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3970-7. PubMed ID: 15840739
    [Abstract] [Full Text] [Related]

  • 59. Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
    Abrahamsen B, Hangaard J, Horn HC, Hansen TB, Gregersen G, Hansen-Nord M, Vahl N, Junker P, Andersen M, Hagen C.
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):273-81. PubMed ID: 12153608
    [Abstract] [Full Text] [Related]

  • 60. Dynamic pattern of IGF-I and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
    Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D, Ciesielska-Kopacz N.
    Endocr Regul; 2002 Mar; 36(1):9-17. PubMed ID: 11971746
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.